IMS Health (IMS) & Its Competitors Head to Head Survey

IMS Health (NYSE: IMS) is one of 182 publicly-traded companies in the “IT Services & Consulting” industry, but how does it compare to its rivals? We will compare IMS Health to similar companies based on the strength of its valuation, institutional ownership, profitability, earnings, risk, analyst recommendations and dividends.

Earnings and Valuation

This table compares IMS Health and its rivals gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
IMS Health N/A N/A 74.62
IMS Health Competitors $2.79 billion $288.44 million 268.07

IMS Health’s rivals have higher revenue and earnings than IMS Health. IMS Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and recommmendations for IMS Health and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IMS Health 0 0 0 0 N/A
IMS Health Competitors 769 4649 7411 181 2.54

As a group, “IT Services & Consulting” companies have a potential downside of 13.42%. Given IMS Health’s rivals higher possible upside, analysts plainly believe IMS Health has less favorable growth aspects than its rivals.


This table compares IMS Health and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IMS Health 2.99% 5.62% 1.22%
IMS Health Competitors -21.70% -277.89% -4.43%

Insider and Institutional Ownership

90.3% of IMS Health shares are owned by institutional investors. Comparatively, 63.0% of shares of all “IT Services & Consulting” companies are owned by institutional investors. 2.5% of IMS Health shares are owned by insiders. Comparatively, 16.5% of shares of all “IT Services & Consulting” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

About IMS Health

IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company’s principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.

Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit